HMGB1: A promising therapeutic approach for atherosclerosis

被引：11

作者：

Fan, Zhixing ^{[1
]}

Yang, Jian ^{[1
]}

Yang, Jun ^{[1
]}

Yang, Chaojun ^{[1
]}

Guo, Xin ^{[1
]}

机构：

[1] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yichang 443000, Hubei Province, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 202卷

基金：

中国国家自然科学基金;

关键词：

VASCULAR INFLAMMATION; INHIBITION; DISEASES; RECEPTOR;

D O I：

10.1016/j.ijcard.2015.09.101

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：507 / 508

页数：2

共 15 条

[1] HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease
Andrassy, Martin
Volz, H. Christian
Schuessler, Alena
Gitsioudis, Gitsios
Hofmann, Nina
Laohachewin, Danai
Wienbrandt, Alexandra R.
Kaya, Ziya
Bierhaus, Angelika
Giannitsis, Evangelos
Katus, Hugo A.
Korosoglou, Grigorios
[J]. PLOS ONE, 2012, 7 (12):
[2] Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor
Chen, Jing
Zhang, Jing
Xu, Lin
Xu, Changwu
Chen, Sisi
Yang, Jian
Jiang, Hong
[J]. ATHEROSCLEROSIS, 2012, 224 (02) : 332 - 339
[3] HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis
de Souza, A. W. S.
Westra, J.
Limburg, P. C.
Bijl, M.
Kallenberg, C. G. M.
[J]. AUTOIMMUNITY REVIEWS, 2012, 11 (12) : 909 - 917
[4] Ding HS, 2010, SAUDI MED J, V31, P486
[5] HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9
Hirata, Yoichiro
Kurobe, Hirotsugu
Higashida, Mayuko
Fukuda, Daiju
Shimabukuro, Michio
Tanaka, Kimie
Higashikuni, Yasutomi
Kitagawa, Tetsuya
Sata, Masataka
[J]. ATHEROSCLEROSIS, 2013, 231 (02) : 227 - 233
[6] HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
Inoue, Katsumi
Kawahara, Ko-ichi
Biswas, Karnal Krishna
Ando, Kenji
Mitsudo, Kazuaki
Nobuyoshi, Masakiyo
Maruyama, Ikuro
[J]. CARDIOVASCULAR PATHOLOGY, 2007, 16 (03) : 136 - 143
[7] Atherosclerosis: Recent trials, new targets and future directions
Ladeiras-Lopes, Ricardo
Agewall, Stefan
Tawakol, Ahmed
Staels, Bart
Stein, Evan
Mentz, Robert J.
Leite-Moreira, Adelino
Zannad, Faiez
Koenig, Wolfgang
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 192 : 72 - 81
[8] Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE-/- mice by downregulating the HMGB1-RAGE axis
Liu, Ming
Yu, Ying
Jiang, Hong
Zhang, Lei
Zhang, Pei-pei
Yu, Peng
Jia, Jian-guo
Chen, Rui-zhen
Zou, Yun-zeng
Ge, Jun-bo
[J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) : 830 - 836
[9] An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Musumeci, Domenica
Roviello, Giovanni N.
Montesarchio, Daniela
[J]. PHARMACOLOGY & THERAPEUTICS, 2014, 141 (03) : 347 - 357
[10] Umahara T, 2014, HISTOL HISTOPATHOL, V29, P235, DOI 10.14670/HH-29.235

← 1 2 →